Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

RIVAC regimen

A regimen consisting of rituximab, ifosfamide, cytarabine and etoposide that can be used in the treatment of non-Hodgkin lymphoma (NHL).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:R-IVAC regimen
rituximab + ifosfamide + cytarabine + etoposide
rituximab-ifosfamide-cytarabine-etoposide
rituximab/ifosfamide/cytarabine/etoposide
rituximab/ifosphamide/VP-16/ARA-C
Abbreviation:R-IVAC
RIVAC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search